Midostaurin

Definition: Midostaurin, sold under the brand name Rydapt by Novartis, is a multi-targeted protein kinase inhibitor that has been investigated for the treatment of acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) and advanced systemic mastocytosis. It is a semi-synthetic derivative of staurosporine, an alkaloid from the bacterium Streptomyces staurosporeus. source: Wikipedia

ID

763613005

ID date

7 Jan 2022

Previous ID

35307711000001104

Name

Midostaurin